anti hdac1 (Abcam)
Structured Review

Anti Hdac1, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 106 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ab198495/Recombinant+Dengue+virus+2+Dengue+Virus+NS1+glycoprotein/pmc10344782-337-31-33
Average 99 stars, based on 106 article reviews
Images
1) Product Images from "Dynamic de novo heterochromatin assembly and disassembly at replication forks ensures fork stability"
Article Title: Dynamic de novo heterochromatin assembly and disassembly at replication forks ensures fork stability
Journal: Nature Cell Biology
doi: 10.1038/s41556-023-01167-z
Figure Legend Snippet: a , Left: representative images of PLA depicting H3K9me3 presence at replication sites (H3K9me3-EdU PLA, red). Nuclei were counterstained with DAPI (blue). Right: distribution of the total intensity of all H3K9me3-EdU PLA spots per nucleus in wild-type cells (WT), G9a knockout cells (G9a−/−) and wild-type cells treated with 1 µM UNC0642 (UNC0642). Cells were labelled with EdU for 20 min and were either left untreated (UT), treated with 1 mM HU for 1 h (HU) or treated with 1 mM HU for 1 h and released from HU for 25 min and labelled with EdU for 20 min (Rel). ( n WT-UT = 2,436, n WT-HU = 2,212, n WT-REL = 2,340, n G9aKO-UT = 1,038, n G9aKO-HU = 1,168, n G9aKO-REL = 1,074, n UNC0642-UT = 2,413, n UNC0642-HU = 2,328, n UNC0642-REL = 2,315 cells analysed). b – d , Same as a but showing the distribution of PLA spot intensity per nucleus for H3K9me1-EdU PLA ( n WT-UT = 1,346, n WT-HU = 1,050, n WT-REL = 1,192, n G9aKO-UT = 1,543, n G9aKO-HU = 1,470, n G9aKO-REL = 1,630, n UNC0642-UT = 1,502, n UNC0642-HU = 1,296, n UNC0642-REL = 1,338 cells analysed) ( b ), H3K9me2-EdU PLA ( n WT-UT = 1,442, n WT-HU = 1,431, n WT-REL = 1,338, n G9aKO-UT = 1,321, n G9aKO-HU = 1,381, n G9aKO-REL = 1,380, n UNC0642-UT = 1,367, n UNC0642-HU = 1,490, n UNC0642-REL = 1,411 cells analysed) ( c ) and G9a-EdU PLA ( n WT-UT = 1,407, n WT-HU = 1,086, n WT-REL = 1,502, n G9aKO-UT = 1,510, n G9aKO-HU = 1,513, n G9aKO-REL = 1,510, n UNC0642-UT = 1,504, n UNC0642-HU = 1,505, n UNC0642-REL = 1,501 cells analysed) ( d ). e , Distribution of H3K9me3-EdU (left) or G9a-EdU (right) total PLA spot intensity per nucleus of wild-type cells treated (ATRi+) or not (ATRi−) with 10 µM ATR inhibitor and EdU labelled for 20 min followed by a 1 mM HU treatment for 1 h. For H3K9me3-EdU PLA: n HU− = 909, n HU+ = 931; for G9a-EdU PLA: n HU− = 869, n HU+ = 1,080 cells analysed. f , Same as a but showing the distribution of H3K9me3-EdU total PLA spot intensity per nucleus for the indicated conditions ( n ctl-UT = 1,509, n ctl-HU = 1,509, n ctl-REL = 1,506, n UNC0642-UT = 2,003, n UNC0642-HU = 1,529, n UNC0642-REL = 1,543, n siSUV39h1-UT = 1,514, n siSUV39h1-HU = 1,502, n siSUV39h1-REL = 1,500, n UNC0642+siSUV39h1-UT = 1,502, n UNC0642+siSUV39h1-HU = 1,523, n UNC0642+siSUV39h1-REL = 1,507, cells analysed) (note that, for a – f , blue dashed indicates mean of the distribution, **** P ≤ 0.0001, *** P ≤ 0.001, ** P ≤ 0.01, * P ≤ 0.05, NS, non-significant, one-way analysis of variance Kruskal–Wallis test followed by Dunn’s test is used for all statistical analysis). g , Model summarizing G9a and SUV39h1 role at stalled replication forks. Upon replication stress, checkpoint-regulated G9a activity at stressed replication forks results in transient accumulation of H3K9me1/2 allowing SUV39h1 to catalyse H3K9me3 modification. Further accumulating HDAC1 resulted in the loss of H4K16ac. Figure created with biorender.com . h , Representative images of the changes over time of a stripe of photo-activated GFP-H2A for the indicated conditions. This experiment was reproduced independently three times with similar results. i , Mean photo-activated GFP-H2A area over time relative to the area at T = 0 min in percentage ± standard deviation. In PCNA negative (black) and positive (red) for untreated cell: WT-UT (left), cells undergoing replication stress: WT + HU (middle) and cells undergoing replication stress in the absence of G9a activity (right). Unpaired two-sided t -test, **** P ≤ 0.0001, ** P ≤ 0.01. For experimental design, see Extended Data Fig. . n = 3 independent experiments. Source numerical data are available in .
Techniques Used: Knock-Out, Activity Assay, Modification, Standard Deviation
Figure Legend Snippet: ( a ) Plot showing distribution of H3K9me3-EdU total PLA spot intensity per nucleus for the indicated conditions. (n siCTL-UT = 925, n siCTL-HU = 951, n siCTL-REL = 990, n siSETDB1-UT = 1071, n siSETDB1-HU = 1040, n siSETDB1-REL = 1138 cells analyzed; blue dashed line represents the mean of the distribution, **** = P ≤ 0.0001, * = P ≤ 0.05, ns = non-significant, Kruskal-Wallis test followed by Dunn’s test). ( b ) Analysis of ChromStretch fibers to assess the dynamics of H3K9me1 at replication upon replication stress. Quantification of H3K9me1 signal overlapping with EdU for the indicated condition. The signal is represented as a fold increase compared to the mean H3K9me1 signal of the untreated condition. (n siCTL-UT = 100, n siCTL-HU = 100, n siSUV39h1-UT = 132, n siSUV39h1-HU = 100, n siSUV39h1+UNC0642-UT = 87, n siSUV39h1+UNC0642-HU = 100 cells analyzed; **** = P ≤ 0.0001, ns = non-significant, Kruskal-Wallis test followed by Dunn’s test). ( c ) Plot showing distribution of HDAC1-EdU total PLA spot intensity per nucleus for the indicated conditions. (n WT-UT = 1691, n WT-HU = 1871, n WT-REL = 1771, n UNC0642-UT = 1534, n UNC0642-HU = 1798, n UNC0642-REL = 1652 cells analyzed; blue dashed line represents the mean of the distribution, **** = P ≤ 0.0001, ** = P ≤ 0.01,Kruskal-Wallis test followed by Dunn’s test). ( d ) Plot showing distribution of H4K16ac-EdU total PLA spot intensity per nucleus for the indicated conditions. (n WT-UT = 1507, n WT-HU = 1254, n WT-REL = 1489, n UNC0642-UT = 1187, n UNC0642-HU = 1488, n UNC0642-REL = 1365 cells analyzed; **** = P ≤ 0.0001, ** = P ≤ 0.01, * = P ≤ 0.05, ns = non-significant, Kruskal-Wallis test followed by Dunn’s test). ( e ) Chromatin compaction can be followed in replicating (PCNA positive) and non-replicating (PCNA negative) cells in which a stripe of photo-activable GFP-H2A has been activated. Adding HU and/or UNC0642 immediately after the activation of GFP-H2A allow to measure over time the impact of these drugs on chromatin compaction. Figure created with biorender.com . Source numerical data are available in source data.
Techniques Used: Activation Assay
Figure Legend Snippet: a , b , Combined mean expression was calculated to distinguish TCGA patients with ovarian cancer with low or high GLP/G9a expression , , . Kaplan–Meier curves were generated against progression-free survival ( a ) and overall patient survival ( b ) ( n = 614 patients). P values were calculated with the use of a two-sided log-rank test. c , G9a/EHMT2 associated with replication forks is activated by canonical DNA replication checkpoint pathway to catalyse H3K9me1/me2 at replication forks upon replication stress. Activated G9a generates a platform of H3K9me1/me2/me3 in concert with Suv39h1 at the site of stressed replication forks, which subsequently recruits histone deacetylase, HDAC1 to deacetylate the nucleosomes. Such closed chromatin conformation may create a protective compaction bubble that protects replication forks by (1) promoting efficient recruitment of fork protection factors, BARD1-BRCA1; and (2) such a conformation may also prevent the access to DNA nucleases and other detrimental factors, such as PRIMPOL that can lead to accumulation of ssDNA gaps behind the replication forks. Furthermore, synergistic activity of G9a and Suv39h1 further prevents the substrate, H3K9me1/me2 nucleosomes, availability to H3K9-demethylase, JMJD1A/KDM3A, timely assembly of which facilitates the disassembly of heterochromatin to promote their fork restart. Figure created with biorender.com . Source numerical data are available in .
Techniques Used: Expressing, Generated, Histone Deacetylase Assay, Activity Assay
Related Articles
Negative Control:Article Title: The long non-coding RNA NEAT1 is a ΔNp63 target gene modulating epidermal differentiation Article Snippet: .. The antibodies used were as follows: rabbit anti-p63α (D2K8X; Cell Signaling), Proximity Ligation Assay:Article Title: Dynamic de novo heterochromatin assembly and disassembly at replication forks ensures fork stability Article Snippet: .. Primary antibodies used for PLA are: Anti-Biotin antibody (A150-109A, Bethyl Laboratories), Anti-Biotin antibody (AB_2339006, JacksonImmunoResearch), Anti-H3K9me3 (EPR16601) (Ab176916, Abcam), Anti-H3K9me2 (Ab1220, Abcam), Anti-H3K9me1 (EPR16989) (Ab176880, Abcam), Anti-G9a (EPR18894) (Ab 185050, Abcam), Activity Assay:Article Title: Cathepsin L regulates oocyte meiosis and preimplantation embryo development Article Snippet: .. Lactoferrin from bovine milk (LF; #L9507, Sigma) was dissolved in water and added to IVM/IVC medium at 10, 100 or 1000 μg/mL to inhibit CTSL activity in good quality oocytes/embryos while recombinant Recombinant:Article Title: Cathepsin L regulates oocyte meiosis and preimplantation embryo development Article Snippet: .. Lactoferrin from bovine milk (LF; #L9507, Sigma) was dissolved in water and added to IVM/IVC medium at 10, 100 or 1000 μg/mL to inhibit CTSL activity in good quality oocytes/embryos while recombinant Control:Article Title: The growth hormone receptor interacts with transcriptional regulator HMGN1 upon GH-induced nuclear translocation Article Snippet: .. Antibodies used in the experiments were GHR extracellular domain (Abcam, ab89400) GHR intracellular domain (Santa Cruz Biotechnology, sc-137185), HMGN1 (Invitrogen Life Technologies, 720,387), SUMO1 (Invitrogen Life Technologies, 332,400), |

